These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16828010)

  • 21. Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention.
    Guo S
    J Endocrinol; 2014 Feb; 220(2):E1-3. PubMed ID: 24431466
    [No Abstract]   [Full Text] [Related]  

  • 22. Dysmetabolic syndrome: reducing cardiovascular risk.
    Appel SJ; Giger JN; Floyd NA
    Nurse Pract; 2004 Oct; 29(10):18-35; quiz 35-7. PubMed ID: 15489668
    [No Abstract]   [Full Text] [Related]  

  • 23. [Metabolic syndrome as a gerontological problem (literature review).].
    Karpin VA
    Adv Gerontol; 2020; 33(3):479-487. PubMed ID: 33280332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin use in the metabolic syndrome.
    Lundbye JB; Thompson PD
    Curr Atheroscler Rep; 2005 Feb; 7(1):17-21. PubMed ID: 15683597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome.
    Bloomgarden ZT
    Diabetes Care; 2004 Mar; 27(3):824-30. PubMed ID: 14988311
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin resistance, the metabolic syndrome and risk of cardiovascular disease: a complex story.
    Issa BG; Hanna FW
    Curr Opin Lipidol; 2003 Aug; 14(4):405-7. PubMed ID: 12865741
    [No Abstract]   [Full Text] [Related]  

  • 27. [The metabolic syndrome and inflammation: actual issues of pathogenesis].
    Sveklina TS; Talantseva MS; Barsukov AV
    Klin Lab Diagn; 2013 Mar; (3):7-10. PubMed ID: 23808015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensified screening and treatment of the metabolic syndrome for cardiovascular risk reduction.
    Wong ND
    Prev Cardiol; 2005; 8(1):47-52; quiz 53-4. PubMed ID: 15722694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study.
    Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
    Diabetes; 2005 Nov; 54(11):3252-7. PubMed ID: 16249452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance.
    Tuan CY; Abbasi F; Lamendola C; McLaughlin T; Reaven G
    Am J Cardiol; 2003 Sep; 92(5):606-10. PubMed ID: 12943888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aerobic, resistance or combined training: A systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome.
    Wewege MA; Thom JM; Rye KA; Parmenter BJ
    Atherosclerosis; 2018 Jul; 274():162-171. PubMed ID: 29783064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second World Congress on the Insulin Resistance Syndrome: hypertension, cardiovascular disease, and treatment approaches.
    Bloomgarden ZT
    Diabetes Care; 2005 Aug; 28(8):2073-80. PubMed ID: 16043765
    [No Abstract]   [Full Text] [Related]  

  • 33. The metabolic syndrome: diagnosis and treatment.
    Zieve FJ
    Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome.
    Robins SJ
    Curr Cardiol Rep; 2005 Nov; 7(6):457-64. PubMed ID: 16256016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic inflexibility in skeletal muscle: a prelude to the cardiometabolic syndrome?
    Thyfault JP; Rector RS; Noland RC
    J Cardiometab Syndr; 2006; 1(3):184-9. PubMed ID: 17679820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syndrome X: clinical aspects.
    Labadarios D
    World Rev Nutr Diet; 2005; 94():68-74. PubMed ID: 16145252
    [No Abstract]   [Full Text] [Related]  

  • 37. The insulin resistance syndrome.
    Reaven GM
    Curr Atheroscler Rep; 2003 Sep; 5(5):364-71. PubMed ID: 12911846
    [No Abstract]   [Full Text] [Related]  

  • 38. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention.
    Osibogun O; Ogunmoroti O; Michos ED
    Trends Cardiovasc Med; 2020 Oct; 30(7):399-404. PubMed ID: 31519403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing cardiovascular disease and diabetes: a call to action from the ADA and AHA.
    Wyne KL
    J Cardiometab Syndr; 2006; 1(3):220-1. PubMed ID: 17679801
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiometabolic syndrome: pathophysiology and treatment.
    Castro JP; El-Atat FA; McFarlane SI; Aneja A; Sowers JR
    Curr Hypertens Rep; 2003 Oct; 5(5):393-401. PubMed ID: 12948432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.